−14.36USD
−13.98 MUSD
5.33 MUSD
596.43 K
About Arcadia Biosciences, Inc.
Sector
CEO
Stanley E. Jacot
Headquarters
Dallas
Website
Employees (FY)
21
Founded
2002
ISIN
US0390143032
FIGI
BBG000GYBX66
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RKDA is 2.06 USD — it has increased by 5.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arcadia Biosciences, Inc. stocks are traded under the ticker RKDA.
Arcadia Biosciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
RKDA stock is 7.81% volatile and has beta coefficient of 0.31. Check out the list of the most volatile stocks — is Arcadia Biosciences, Inc. there?
One year price forecast for Arcadia Biosciences, Inc. has a max estimate of 12.00 USD and a min estimate of 10.00 USD.
RKDA earnings for the last quarter are −1.89 USD per share, whereas the estimation was −2.93 USD resulting in a 35.49% surprise. The estimated earnings for the next quarter are −2.59 USD per share. See more details about Arcadia Biosciences, Inc. earnings.
Arcadia Biosciences, Inc. revenue for the last quarter amounts to 1.60 M USD despite the estimated figure of 1.55 M USD. In the next quarter revenue is expected to reach 1.75 M USD.
Yes, you can track Arcadia Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
RKDA stock has risen by 5.91% compared to the previous week, the month change is a 12.71% fall, over the last year Arcadia Biosciences, Inc. has showed a 70.19% decrease.
RKDA net income for the last quarter is −2.85 M USD, while the quarter before that showed −2.57 M USD of net income which accounts for −11.14% change. Track more Arcadia Biosciences, Inc. financial stats to get the full picture.
Today Arcadia Biosciences, Inc. has the market capitalization of 1.20 M, it has increased by 4.50% over the last week.
No, RKDA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RKDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arcadia Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 21.00 employees. See our rating of the largest employees — is Arcadia Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Arcadia Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Arcadia Biosciences, Inc. stock shows the sell signal. See more of Arcadia Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Arcadia Biosciences, Inc. future price: according to them, RKDA price has a max estimate of 12.00 USD and a min estimate of 10.00 USD. Read a more detailed Arcadia Biosciences, Inc. forecast: see what analysts think of Arcadia Biosciences, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Arcadia Biosciences, Inc. EBITDA is −13.39 M USD, and current EBITDA margin is −241.67%. See more stats in Arcadia Biosciences, Inc. financial statements.